Gene · 9402
GRAP2: GRB2 related adaptor protein 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. GRAP2: GRB2 related adaptor protein 2. Genes, record 9402. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9402
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O75791 | GRB2-related adapter protein 2 | 330 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents29
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 48237 | O75791 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 48239 | O75791 | Espacenet |
| EP 4661970 A1 | 2025-12-17 | 62149 | O75791 | Espacenet |
| EP 4484957 A1 | 2025-01-01 | 14 | O75791 | Espacenet |
| WO 2023162878 A | 2023-08-31 | 14 | O75791 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 36316 | O75791 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 36317 | O75791 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 139287 | O75791 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 139288 | O75791 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 4701 | O75791 | Espacenet |
1 to 10 of 29
See all 29 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants993
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GRAP2 papers | Newest fiscal year |
|---|---|---|---|
| ZIABC010304 | Biochemical Basis of T Cell Activation | 12 | 2025 |
| P01AI091580 | Defining the Unique Properties of the Distinct Signaling Machinery Used by the TCR | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 5 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 5 | 2025 |
| T32AI007485 | Predoctoral Training Program in Immunology | 4 | 2025 |
| T32DA007209 | Human Behavioral Pharmacology of Substance Abuse | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| ZICBC010978 | Confocal Core for the Laboratory of Cellular and Molecular Biology | 3 | 2025 |
| KL2TR002317 | Institutional Career Development Core | 2 | 2025 |
1 to 10 of 993Source NIH's project files
See all 993 nih grantsPapers1,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood parameters and whole-blood transcriptomics associated with immune-related adverse events in metastatic renal cell carcinoma during nivolumab plus ipilimumab. | Sci Rep | 2026 | 42026114 | PubTator, text mining | PubMed |
| Machine learning model based on plasma proteomics for the identification of Parkinson's disease. | Brain | 2026 | 42015416 | PubTator, text mining | PubMed |
| Generalizable, high-throughput image analysis of subcellular structures using dispersion indices. | iScience | 2026 | 41993690 | PubTator, text mining | PubMed |
| ZBTB7A promotes malignant phenotypes in ovarian cancer through transcriptional activation of CRLF1. | Oncol Rep | 2026 | 41891980 | PubTator, text mining | PubMed |
| KR-62980, a novel PPARγ agonist, inhibits collagen-induced platelet activation and thrombus formation by regulating the GPVI signaling pathway. | Biochem Pharmacol | 2026 | 41871717 | PubTator, text mining | PubMed |
| Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors. | iScience | 2026 | 41767257 | PubTator, text mining | PubMed |
| Understanding diverse subjectivities of medical students in seeking composite role models: A Q-methodology study. | PLoS One | 2026 | 41758802 | PubTator, text mining | PubMed |
| Chromatin Engagement and Transcriptional Activity of the ZNF217 Exon 4-Skipping Isoform Are Associated with Breast Cancer Aggressiveness and Bone Metastasis. | Cancers (Basel) | 2026 | 41749916 | PubTator, text mining | PubMed |
| T Cell Receptor Co-Stimulation Through Magnetogenetic Tools: A Platform for Wireless Rewiring of Cellular Signaling. | ACS Omega | 2026 | 41726657 | PubTator, text mining | PubMed |
| Optimal GRID-HAM-D7 cut-off scores for defining remission in older Thai adults with depression. | Front Psychiatry | 2026 | 41696477 | PubTator, text mining | PubMed |
1 to 10 of 1,586
See all 1,586 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9402
GET https://conductscience.org/api/genes/v1/9402/patents?page=2